Flavoxate hydrochloride at a daily dosage of 600 mg was compared to a daily dosage of 1200 mg for the treatment of unstable bladder. Twenty-seven patients were treated for 4 weeks in a double-blind, randomized, parallel-group trial. Clinically, both schedules were equally successful. In urodynamic terms, however, particularly with respect to uninhibited detrusor contractions, 1200 mg/day was significantly superior to 600 mg/day. Tolerability was excellent for both regimens. The side-effect free treatment of urgency and urge incontinence is of paramount importance for a patient's quality of life.
MilaniRScalambrinoSCarreraS: Flavoxate hydrochloride for urinary urgency after pelvic radiotherapy: comparison of 600 mg versus 1200 mg daily dosages. J Int Med Res1988; 16: 71–74.
2.
MoiseyCUStephensonTPBrendlerCB: The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride. Br J Urol1980; 52: 472–475.
3.
RuffmannRSartaniA: Flavoxate, a drug with smooth muscle relaxing activity. Drug Exp Clin Res1987; 13: 57–62.
4.
AbbiatiGCeseraniRNardiD: Receptor binding studies of Rec 15-2053, and other bladder spasmolytics. Pharm Res1988 (in press).
